nafamostat has been researched along with Apoplexy in 3 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors retrospectively identified the patients who received nafamostat mesilate and who suffered symptomatic ischemic stroke within 30 postoperative days." | 7.78 | Nafamostat mesilate, as a treatment for heparin resistance, is not associated with perioperative ischemic stroke in patients undergoing cardiac surgery with cardiopulmonary bypass. ( Hiraiwa, T; Kikura, M; Tanaka, K, 2012) |
| "NM treatment attenuated the brain infarct volume and the loss of body weight and improved the recovery of sensorimotor and cognitive functions." | 5.46 | Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats. ( Fang, Y; Li, C; Liao, H; Liu, Y; Sun, H; Tao, X; Wang, J; Zhou, XF, 2017) |
| "The authors retrospectively identified the patients who received nafamostat mesilate and who suffered symptomatic ischemic stroke within 30 postoperative days." | 3.78 | Nafamostat mesilate, as a treatment for heparin resistance, is not associated with perioperative ischemic stroke in patients undergoing cardiac surgery with cardiopulmonary bypass. ( Hiraiwa, T; Kikura, M; Tanaka, K, 2012) |
| "NM treatment attenuated the brain infarct volume and the loss of body weight and improved the recovery of sensorimotor and cognitive functions." | 1.46 | Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats. ( Fang, Y; Li, C; Liao, H; Liu, Y; Sun, H; Tao, X; Wang, J; Zhou, XF, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Li, C | 1 |
| Wang, J | 1 |
| Fang, Y | 1 |
| Sun, H | 1 |
| Tao, X | 1 |
| Zhou, XF | 1 |
| Liao, H | 1 |
| Kikura, M | 1 |
| Tanaka, K | 2 |
| Hiraiwa, T | 1 |
| Morimoto, N | 1 |
| Henmi, S | 1 |
| Yoshida, M | 1 |
| Mukohara, N | 1 |
3 other studies available for nafamostat and Apoplexy
| Article | Year |
|---|---|
Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats.
Topics: Animals; Axons; Benzamidines; Body Weight; Brain Infarction; Cognition; Cyclic AMP Response Element- | 2017 |
Nafamostat mesilate, as a treatment for heparin resistance, is not associated with perioperative ischemic stroke in patients undergoing cardiac surgery with cardiopulmonary bypass.
Topics: Aged; Benzamidines; Brain Ischemia; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cohort Stud | 2012 |
Cardiopulmonary bypass strategy with low-dose heparin and nafamostat mesilate in cardiac surgery: a safe option for patients with acute stroke.
Topics: Aged; Aged, 80 and over; Anticoagulants; Benzamidines; Cardiac Surgical Procedures; Cardiopulmonary | 2012 |